Comparison of the biological availability of retard and non-retard lisuride tablets in dogs
Lapka, R.; Pospísil, A.; Sedlmayer, P.; Rejholec, V.; Rezanka, V.; Smolík, S.; Franc, Z.
Ceskoslovenska Farmacie 34(1): 3-6
1985
ISSN/ISBN: 0009-0530 PMID: 3986933 Document Number: 264861
Document emailed within 1 workday
Related Documents
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87Panda, N.C.; Parija, C.R.; Tripathy, B.B. 1973: Plasma levels of 17-hydroxy steroids following plain and retard tablets of prednisolone Journal of the Association of Physicians of India 21(7): 589-596
Chalabala, M.; Starha, L. 1970: Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard Ceskoslovenska Farmacie 19(5): 184-186
Pivac, N.; Dobovisek, J.; Bagatin, J.; Gros Furek, V.; Rumboldt, Z.; Janezić, A.; Kveder, R.; Sjerobabski, V.; Simunić, M.; Sardelić, S. 1993: Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension Lijecnicki Vjesnik 115(11-12): 356-359
Zehender, M.; Geibel, A.; Hust, M.; Hohnloser, S.; Meinertz, T.; Just, H. 1987: Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine Zeitschrift für Kardiologie 76(8): 501-506
Bremner, A.D.; Fell, P.J.; Hosie, J.; James, I.G.; Saul, P.A.; Taylor, S.H. 1993: Early side-effects of antihypertensive therapy: comparison of amlodipine and nifedipine retard Journal of Human Hypertension 7(1): 79-81
Marenco, G.; Dante, G.L.; Arzillo, G.P.; Frascio, M.; Reboa, G. 1985: Cimetidine in the simple and retard form: comparison of the efficacy and tolerability in the management of duodenal ulcer Panminerva Medica 27(4): 183-187
Ding, Y.A.; Law, H.W.; Chou, T.C. 1994: Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients Journal of Human Hypertension 8(2): 137-143
Drabant, S.; Klebovich, I.; Gachályi, B.; Renczes, G.; Farsang, C. 1998: Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets Acta Pharmaceutica Hungarica 68(5): 294-306
Brinkhoff, H.; Rummel, W. 1974: Extended use of dimenhydrinate (Vomex a retard) Zeitschrift für Allgemeinmedizin 50(9): 456-457
Starzycka, M.; Krukar-Bastrowa, K. 1980: Cosaldon retard in the treatment of certain maculopathies Klinika Oczna 82(6): 315-316
Josefson, D. 1997: Caloric restriction may retard cancers Bmj 315(7119): 1332
Slapke, J.; Hummel, S.; Wilke, A.; Wenz, W.; Meister, W.; Förster, R.; Wiesner, B.; Rentsch, E.; Nussbücker, B. 1988: Clinical use of theophylline retard Oranienburg Zeitschrift für Erkrankungen der Atmungsorgane 170(1): 49-53
Schleef, G. 1970: Experiences with neuroleptic Jatroneural-retard Therapie der Gegenwart 109(5): 714 Passim
Kirby, B.J.; Kitchin, N.R. 1999: A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension International Journal of Clinical Practice 53(5): 339-343
Sedlmayer, P.; Sispera, L.; Rejholec, V.; Chaura, Z. 1984: Biological availability and pharmacological effects of Prazosin VUFB in dogs Ceskoslovenska Farmacie 33(6): 235-237
Heckrodt, K. 1979: Treatment of acoustic trauma with Cetal retard Medizinische Klinik Suppl: 55-56
Schwartzkopff, W.; Schilling, A.; Calder, D. 1980: Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard Die Medizinische Welt 31(14): 515-520
Weindruch, R. 1989: How does dietary restriction retard diseases and aging? Progress in Clinical and Biological Research 287: 97-103
Kopp, H. 1972: Treatment of latent heart insufficiency by Eoden-retard Zeitschrift für Allgemeinmedizin 48(35): 1653-1656